In the News

January 11, 2021

Endpoints News

“Genentech and Biogen roll the dice on an upstart biotech with a new siRNA approach — going deep into the brain for targets in neurodegeneration”

October 14, 2019

Nature Biotechnology

“Two new startups, Triplet Therapeutics and Atalanta Therapeutics, are pushing to bring genetic medicine to patients with Huntington’s disease, adding momentum to an industry drive that was galvanized last year…”

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now